Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No Surprise As Abbott Cuts Loose Angio-Seal, Femoseal To Terumo

Executive Summary

Abbott and St. Jude Medical are to lighten their cardiovascular portfolios – and hopefully facilitate the completion of Abbott's pending $25bn acquisition of St. Jude – by selling three product lines to Terumo. Two of the three product lines to be divested come as little surprise, but one product was acquired by Abbott only earlier this year.

Advertisement

Related Content

Device/Diagnostics Quarterly Deal Statistics, Q4 2016
Final Countdown To St. Jude Acquisition – Abbott Scores US Antitrust Approval
OUS Approvals Analysis: November Product Go-Aheads Headlined by LimFlow, Abbott, Creavo
St. Jude Pauses LEADLESS II Trial Of Nanostim Following Reports Of Lost Telemetry
Cybersecurity Allegations, Safety Alert Will Not Impact St. Jude Acquisition, Abbott Affirms
The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant
MNA Analysis: Abbott And Stryker Make Big Deals In Slow Month
ANALYSIS: Abbott/St Jude Merger Would Make Sense But Vascular Closure Potential Snag

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT103977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel